Lawsuits have been filed against Gilead Sciences, the maker of the HIV drug Truvada, with claims including bone damage and kidney failure. Some lawsuits also allege that the company intentionally delayed development of safer HIV medications, prioritizing profits over patient safety. The status of these lawsuits and potential settlements is being closely watched, with some outlets providing updates on the litigation and possible outcomes.